» Articles » PMID: 24494598

Deletion of the Kv2.1 Delayed Rectifier Potassium Channel Leads to Neuronal and Behavioral Hyperexcitability

Overview
Date 2014 Feb 6
PMID 24494598
Citations 78
Authors
Affiliations
Soon will be listed here.
Abstract

The Kv2.1 delayed rectifier potassium channel exhibits high-level expression in both principal and inhibitory neurons throughout the central nervous system, including prominent expression in hippocampal neurons. Studies of in vitro preparations suggest that Kv2.1 is a key yet conditional regulator of intrinsic neuronal excitability, mediated by changes in Kv2.1 expression, localization and function via activity-dependent regulation of Kv2.1 phosphorylation. Here we identify neurological and behavioral deficits in mutant (Kv2.1(-/-) ) mice lacking this channel. Kv2.1(-/-) mice have grossly normal characteristics. No impairment in vision or motor coordination was apparent, although Kv2.1(-/-) mice exhibit reduced body weight. The anatomic structure and expression of related Kv channels in the brains of Kv2.1(-/-) mice appear unchanged. Delayed rectifier potassium current is diminished in hippocampal neurons cultured from Kv2.1(-/-) animals. Field recordings from hippocampal slices of Kv2.1(-/-) mice reveal hyperexcitability in response to the convulsant bicuculline, and epileptiform activity in response to stimulation. In Kv2.1(-/-) mice, long-term potentiation at the Schaffer collateral - CA1 synapse is decreased. Kv2.1(-/-) mice are strikingly hyperactive, and exhibit defects in spatial learning, failing to improve performance in a Morris Water Maze task. Kv2.1(-/-) mice are hypersensitive to the effects of the convulsants flurothyl and pilocarpine, consistent with a role for Kv2.1 as a conditional suppressor of neuronal activity. Although not prone to spontaneous seizures, Kv2.1(-/-) mice exhibit accelerated seizure progression. Together, these findings suggest homeostatic suppression of elevated neuronal activity by Kv2.1 plays a central role in regulating neuronal network function.

Citing Articles

Channels, Transporters, and Receptors at Membrane Contact Sites.

Casas M, Dickson E Contact (Thousand Oaks). 2025; 7:25152564241305593.

PMID: 39742107 PMC: 11686659. DOI: 10.1177/25152564241305593.


Abnormal cytoskeletal remodeling but normal neuronal excitability in a mouse model of the recurrent developmental and epileptic encephalopathy-susceptibility KCNB1-p.R312H variant.

Bortolami A, Forzisi Kathera-Ibarra E, Balatsky A, Dubey M, Amin R, Venkateswaran S Commun Biol. 2024; 7(1):1713.

PMID: 39738805 PMC: 11685548. DOI: 10.1038/s42003-024-07344-6.


Sex-Dependent Changes in Gonadotropin-Releasing Hormone Neuron Voltage-Gated Potassium Currents in a Mouse Model of Temporal Lobe Epilepsy.

Rajan R, Christian-Hinman C eNeuro. 2024; 11(10).

PMID: 39375030 PMC: 11493494. DOI: 10.1523/ENEURO.0324-24.2024.


The involvement of K channels in depression and pharmacological effects of antidepressants on these channels.

Li X Transl Psychiatry. 2024; 14(1):411.

PMID: 39358318 PMC: 11447029. DOI: 10.1038/s41398-024-03069-6.


Kv2 channels do not function as canonical delayed rectifiers in spinal motoneurons.

Smith C, Nascimento F, Ozyurt M, Beato M, Brownstone R iScience. 2024; 27(8):110444.

PMID: 39148717 PMC: 11325356. DOI: 10.1016/j.isci.2024.110444.


References
1.
Mulholland P, Carpenter-Hyland E, Hearing M, Becker H, Woodward J, Chandler L . Glutamate transporters regulate extrasynaptic NMDA receptor modulation of Kv2.1 potassium channels. J Neurosci. 2008; 28(35):8801-9. PMC: 2612131. DOI: 10.1523/JNEUROSCI.2405-08.2008. View

2.
Judge S, Smith P, Stewart P, Bever Jr C . Potassium channel blockers and openers as CNS neurologic therapeutic agents. Recent Pat CNS Drug Discov. 2008; 2(3):200-28. DOI: 10.2174/157488907782411765. View

3.
Korngreen A, Sakmann B . Voltage-gated K+ channels in layer 5 neocortical pyramidal neurones from young rats: subtypes and gradients. J Physiol. 2000; 525 Pt 3:621-39. PMC: 2269970. DOI: 10.1111/j.1469-7793.2000.00621.x. View

4.
Maiya R, Ponomarev I, Linse K, Harris R, Mayfield R . Defining the dopamine transporter proteome by convergent biochemical and in silico analyses. Genes Brain Behav. 2006; 6(1):97-106. DOI: 10.1111/j.1601-183X.2006.00236.x. View

5.
Ralph R, Paulus M, Fumagalli F, Caron M, Geyer M . Prepulse inhibition deficits and perseverative motor patterns in dopamine transporter knock-out mice: differential effects of D1 and D2 receptor antagonists. J Neurosci. 2001; 21(1):305-13. PMC: 6762423. View